Guillaume Emmanuel Beranger

6PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMetabolic medicineMolecular targetsBiologically active moleculesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 19, 2021
FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.

Nadia Habel, Najla El-Hachem, Frédéric Soysouvanh

|Jan 15, 2021
Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma.

Henri Montaudié, Guillaume Emmanuel Beranger, Frédéric Reinier

|Jan 12, 2021
Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies.

Emilie Jaune, Elisa Cavazza, Cyril Ronco

|Mar 09, 2018
Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells.

Najla El-Hachem, Nadia Habel, Tanesha Naiken

Pageof 1